UNSPSC 51172302: Digoxin Immune Fab

This classification denotes an antitdote for digitalis overdose with the molecular formula C6394H9908N1698O2011S58, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YB12NQZ1YN.

UNSPSC 51172302 Digoxin Immune Fab is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity in the dataset—Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services—does not involve digoxin immune fab procurement. That RFP solicits drug screening and confirmation testing under immunoassay and LC/MS/MS methodologies, staffing for collection sites, and lab certification compliance, with no reference to antitoxin products or toxicology treatment supplies. The code appears inactive or poorly tagged in state and local procurement channels for the pharmaceutical product its UNSPSC designation identifies.

No recent state and local contract opportunities targeting digoxin immune fab or related cardiac glycoside antitoxins appear in the available data. Buyers seeking this specialized pharmaceutical—typically emergency departments, poison control centers, or hospital pharmacy procurement offices—may source it through cooperative purchasing agreements, direct vendor relationships with pharmaceutical distributors, or standing contracts rather than open competitive solicitations. Business development professionals monitoring this code should verify whether state and local health systems, correctional medical services, or emergency management agencies have posted related RFPs under alternate UNSPSC classifications or whether procurement for digoxin immune fab remains driven by manufacturer direct sales and pharmaceutical group purchasing organizations.